{"doi":"10.17615/mcq6-3a51","title":"Unknown","abstract":null,"journal":null,"year":null,"id":601656,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257","abstract":"Background. Metabolic effects following combination antiretroviral therapy (cART) vary by regimen type. Changes in metabolic effects were assessed following cART in the AIDS Clinical Trials Group (ACTG) A5257 study, and correlated with plasma ritonavir trough concentrations (C24).","is_dataset_classified":null,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"23304386","pmcid":null,"openalex_id":"https://openalex.org/W4300529029","authors":[],"funders":[{"funder_name":"National Institutes of Health","grant_id":"3UL1RR024156-02S1","title":"Adapting the RAO Model to Four Types of Community-based Providers"},{"funder_name":"National Institutes of Health","grant_id":"5U01AI069447-05","title":"Institute of Human Virology Clinical Trials Unit"},{"funder_name":"National Institutes of Health","grant_id":"3UL1TR000457-08S1","title":"Clinical and Translational Science Center"},{"funder_name":"National Institutes of Health","grant_id":"2UM1AI069418-15","title":"Emory-CDC CTU"},{"funder_name":"National Institutes of Health","grant_id":"5UM1AI069432-17","title":"UCSD Collaborative Clinical Trials Unit"},{"funder_name":"National Institutes of Health","grant_id":"2UM1AI069412-08","title":"Harvard/Boston/Providence Clinical Trials Unit (Harvard/B/P CTU)"},{"funder_name":"National Institutes of Health","grant_id":"5P30AI050410-05","title":"UNC Center for Aids Research"},{"funder_name":"National Institutes of Health","grant_id":"2UM1AI069439-08","title":"Vanderbilt HIV Clinical Trials Unit"},{"funder_name":"National Institutes of Health","grant_id":"3U01AI069494-05S1","title":"University of Pittsburgh Clinical Trials Unit"},{"funder_name":"National Institutes of Health","grant_id":"5UM1AI069472-06","title":"Partners Healthcare Systems/Harvard Medical School/Boston Medical Center AIDS CTU"},{"funder_name":"National Institutes of Health","grant_id":"5UM1AI068634-09","title":"Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)"},{"funder_name":"National Institutes of Health","grant_id":"5UM1AI069532-06","title":"New York University HIV/AIDS Clinical Trial Unit"},{"funder_name":"National Institutes of Health","grant_id":"5UM1AI069419-10","title":"Weill Cornell Medical College-New Jersey Medical School Clinical Trials Unit"},{"funder_name":"National Institutes of Health","grant_id":"5UM1AI069423-18","title":"University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit"},{"funder_name":"National Institutes of Health","grant_id":"5UL1TR000124-04","title":"UCLA Clinical and Translational Science Institute"},{"funder_name":"National Institutes of Health","grant_id":"2UL1TR000439-06","title":"Clinical and Translational Science Collaborative of Cleveland"},{"funder_name":"National Institutes of Health","grant_id":"8UL1TR000058-03","title":"Center for Clinical and Translational Research"},{"funder_name":"National Institutes of Health","grant_id":"5UM1AI069511-10","title":"University of Rochester HIV/AIDS Clinical Trials Unit"},{"funder_name":"National Institutes of Health","grant_id":"6UL1TR000445-11","title":"The Vanderbilt Institute for Clinical and Translational Research (VICTR)"},{"funder_name":"National Institutes of Health","grant_id":"5P30AI045008-10","title":"Core--Immunology Facility"},{"funder_name":"National Institutes of Health","grant_id":"2UM1AI069415-09","title":"Integrated University of Puerto Rico Clinical Trials Unit"},{"funder_name":"National Institutes of Health","grant_id":"5U01AI069471-04","title":"Northwestern University Clinical Trial Unit"},{"funder_name":"National Institutes of Health","grant_id":"5UM1AI069484-07","title":"HIV/AIDS Clinical Trials Unit"},{"funder_name":"National Institutes of Health","grant_id":"5UL1TR000454-07","title":"Atlanta Clinical and Translational Science Institute (ACTSI) Renewal"},{"funder_name":"National Institutes of Health","grant_id":"5UM1AI069465-06","title":"Johns Hopkins AIDS Clinical Trials Unit"},{"funder_name":"National Institutes of Health","grant_id":"8UL1TR000170-05","title":"Harvard Clinical and Translational Science Center (UL1)"},{"funder_name":"National Institutes of Health","grant_id":"2UM1AI069452-08","title":"Alabama Clinical Trials Unit"},{"funder_name":"National Institutes of Health","grant_id":"5UL1TR001111-05","title":"North Carolina Translational & Clinical Sciences Institute (NC TraCS)"},{"funder_name":"National Institutes of Health","grant_id":"2UM1AI069503-08","title":"Terry Beirn CPCRA Clinical Trials Unit"},{"funder_name":"National Institutes of Health","grant_id":"3UL1TR001079-02S1","title":"Institute for Clinical and Translational Research"},{"funder_name":"National Institutes of Health","grant_id":"5UM1AI069496-09","title":"San Francisco Bay Clinical Trials Unit"},{"funder_name":"National Institutes of Health","grant_id":"2UM1AI069470-08","title":"Columbia  Partnership for Prevention and Control of HIV/AIDS Clinical Trials Unit"},{"funder_name":"National Institutes of Health","grant_id":"3UM1AI068636-19SC","title":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections"},{"funder_name":"National Institutes of Health","grant_id":"1P30AI060354-01","title":"Harvard Medical School Center for AIDS Research"},{"funder_name":"National Institutes of Health","grant_id":"5P30AI050409-20","title":"Center for AIDS Research at Emory University"},{"funder_name":"National Institutes of Health","grant_id":"5UL1TR001082-05","title":"Colorado Clinical and Translational Sciences Institute"}],"total_grants":36,"fwci":0.0,"citation_percentile":0.41934454,"influential_citations":0,"citation_trend":[],"oa_status":"green","license":null,"oa_locations":[{"url":"https://doi.org/10.17615/mcq6-3a51","host_type":"repository"},{"url":"https://doi.org/10.1093/cid/civ193","host_type":""},{"url":"https://academic.oup.com/cid/article-pdf/60/12/1842/16788813/civ193.pdf","host_type":""},{"url":"https://dx.doi.org/10.17615/mcq6-3a51","host_type":""},{"url":"https://pubmed.ncbi.nlm.nih.gov/25767256","host_type":""},{"url":"https://dx.doi.org/10.1093/cid/civ193","host_type":""},{"url":"https://escholarship.org/uc/item/99f752jd","host_type":""},{"url":"https://doi.org/https://doi.org/10.1093/cid/civ193","host_type":""}],"fields_of_study":["HIV-related health complications and treatments","Liver Disease Diagnosis and Treatment","HIV/AIDS drug development and treatment","0301 basic medicine","0302 clinical medicine","03 medical and health sciences"],"mesh_terms":[],"keywords":["Raltegravir","Darunavir","Ritonavir","Atazanavir","Pharmacology","Medicine","Virology","Antiretroviral therapy","Human immunodeficiency virus (HIV)","Viral load","Blood Glucose","Male","HIV Infections","11 Medical and Health Sciences (for)","Medical and Health Sciences","AIDS Clinical Trials Group (ACTG) A5257 Team","32 Biomedical and Clinical Sciences (for-2020)","Male (mesh)","Humans (mesh)","Atazanavir Sulfate (mesh)","Raltegravir Potassium (mesh)","Biological Sciences","Combination (mesh)","Lipids","06 Biological Sciences (for)","6.1 Pharmaceuticals","Combination","HIV/AIDS","Drug Therapy, Combination","Female","Adult","Blood Glucose (mesh)","Anti-HIV Agents","Clinical Sciences","Atazanavir Sulfate","cART","HIV Infections (mesh)","Microbiology","metabolic syndrome","Drug Therapy","Raltegravir Potassium","616","Humans","3202 Clinical Sciences (for-2020)","6.1 Pharmaceuticals (hrcs-rac)","HIV-1 (mesh)","Biomedical and Clinical Sciences","Ritonavir (mesh)","Lipids (mesh)","Anti-HIV Agents (mesh)","Darunavir (mesh)","Female (mesh)","Microbiology (science-metrix)","Adult (mesh)","HIV-1"],"sdg_mappings":[{"sdg_number":3,"sdg_label":"3. Good health"},{"sdg_number":0,"sdg_label":"Zero hunger"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-29T17:00:19.019576Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}